While it is unknown if nuclear tau influences heterochromatin stability through its localization within heterochromatin19 and through its DNA and RNA binding properties5,23–27, loss of nuclear tau and changes in its phosphorylation state have been observed with Alzheimer’s disease progression17,41,42. Here, MAPT is linked to Alzheimer disease.